Gilead Sciences, Inc.
DARUNAVIR COMBINATION FORMULATIONS

Abstract:

This invention relate to solid oral dosage forms of tire HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulation thereof.